在恒温缩放过程中,ProSAAS优先升高调节,并减少5xFAD小鼠海马体中的粉样斑块负担
Samira Mitias1, Nicholas Schaffer1, Saaya Nair1
1Department of Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Journal of neurochemistry
|August 8, 2024
概括
ProSAAS蛋白有助于维持大脑细胞的稳定性,并可能减少阿尔茨海默病中的粉样质斑块. 这种伴侣蛋白显示动态表达和突触释放,提供潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 蛋白质稳定性 蛋白质稳定性
背景情况:
- 阿尔茨海默病 (AD) 涉及β-粉样蛋白的积累,损害神经元健康和突触功能.
- 恒常性缩放是一种神经元反机制,用于网络稳定性,在AD中可能会受到破坏.
- 普罗萨斯 (pro-small,secretory,chaperone) 是一种高度调节的蛋白质,在恒常性缩放模型中显示出抗聚合性质,并且在体外显示出抗聚合性质.
研究的目的:
- 研究proSAAS在海马蛋白质稳定中的作用及其在阿尔茨海默病进展中的功能.
- 为了比较proSAAS表达动态与其他突触组件在平静缩放期间.
- 在AD小鼠模型中评估proSAAS对β-粉样蛋白病理学的影响.
主要方法:
- 在恒常性缩放过程中,西式涂抹和qPCR将proSAAS表达与突触成分 (7B2,碳氧酶E) 的表达进行比较.
- 在海马培养物中神经元脱极化时释放proSAAS的分析.
- 野生型和5xFAD小鼠的免疫组织化学测试,以评估与粉样斑块相对的proSAAS局部化.
- 在5xFAD小鼠的海马中,立体毒性病毒载体传递 (AAV2/1) 过度表达proSAAS.
主要成果:
- 与7B2和carboxypeptidase E相比,ProSAAS蛋白水平对恒温调节的动态反应显著更高,而mRNA水平保持不变.
- 在脱极化后,ProSAAS从海马神经元释放出来,这表明了突触局部化.
- 在5xFAD小鼠中,在粉样质斑块周围发现了proSAAS.
- 在5xFAD小鼠中过度表达proSAAS降低了粉样蛋白斑块负担.
结论:
- 在proSAAS蛋白表达的动态变化,可能通过翻译控制或改变降解,对于海马蛋白质稳定至关重要.
- 普罗萨斯在正常的恒常性可塑性和在减轻阿尔茨海默病中的蛋白质聚合中发挥作用.
- 在阿尔茨海默病中,ProSAAS代表了减少粉样蛋白病理的潜在治疗标.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...


